Nautilus Biotechnology, Inc. (NAUT) is held by 1 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 2 funds trimming or exiting versus the previous quarter. Latest close $2.43 as of Nov 18, 2026.
Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: none in the last 90 days · Congress to Nov 16, 2026.
Perceptive Advisors — 1 tracked fund hold NAUT. See all holders.
No insider open-market activity or Congress trades reported for this stock in the recent window. Insider trading · Politician trading.
No closely related stocks by co-holding for this stock. Browse all stocks.
| Fund | Portfolio weight | Shares | Change vs prev. quarter |
|---|---|---|---|
| Perceptive Advisors | 0.33% | 11,634,211 | TRIMMED (-7.6%) Q3 filed Nov 16 |
| Polen Capital Management | — | — | EXITED |
Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.
Price change since quarter-end: +28.3% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.
Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.
Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.
| Institutions holding | 93 of 8,857 filers |
| Long-only filers among them | 93 |
| Change vs 2026 Q1 | +13 net · 92 entered · 79 exited |
| Shares reported, all filers | 50,144,583 |
| Reported value, all filers | $89.4M |
Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).
| Exchange | Nasdaq |
| Industry | Laboratory Analytical Instruments (SIC 3826) |
| Net income · FY2025 | $-59.0M |
| Total assets · FY2025 | $191.1M |
| Shares outstanding | 127,372,425 |
| Market cap (at latest close) | $309.5M |
Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Oct 22, 2026.
| Shares short · Oct 15, 2026 | 5,619,648 |
| Share of shares outstanding | 4.41% |
| Days to cover | 1.00 |
Shares short at recent settlements — Jul 31, 2026: 2.3M · Aug 14, 2026: 3.2M · Aug 31, 2026: 3.8M · Sep 15, 2026: 4.1M · Sep 30, 2026: 5.8M · Oct 15, 2026: 5.6M.
Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Oct 22, 2026.
Data unavailable — no Form 4 transactions for this ticker were parsed in the last 90 days.
| Filed | Form | Price change since disclosure |
|---|---|---|
| Sep 11, 2026 | SCHEDULE 13D/A | +160.5% (close Sep 14, 2026 → Nov 17, 2026) |
Reference close is the first trading day after the filing (Sep 14, 2026). A Schedule 13D reports beneficial ownership, not a purchase — there is no transaction price to show. Source: SEC EDGAR Schedule 13D filings.
| Filed | Filer | Form | Shares | % owned | Event date | Source |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | AH Bio Fund II, L.P. | SC 13D/A | 5,782,188 | 4.5% | Sep 9, 2026 | SEC filing |
| Aug 28, 2026 | AH Bio Fund II, L.P. | SC 13D/A | 7,094,691 | 5.6% | Aug 26, 2026 | SEC filing |
| Aug 14, 2026 | Perceptive Advisors LLC | SC 13D/A | 11,634,211 | 9.1% | Jun 30, 2026 | SEC filing |
| Jun 30, 2026 | AH Bio Fund II, L.P. | SC 13D/A | 8,366,966 | 6.6% | Jun 26, 2026 | SEC filing |
| Jun 4, 2026 | AH Bio Fund II, L.P. | SC 13D/A | 11,682,032 | 9.2% | Jun 2, 2026 | SEC filing |
| Mar 4, 2026 | Parag Mallick | SC 13D/A | 22,557,411 | 17.6% | Mar 2, 2026 | SEC filing |
| Mar 4, 2026 | Sujal Patel | SC 13D/A | 21,249,965 | 16.3% | Mar 2, 2026 | SEC filing |
| Jun 24, 2025 | Perceptive Advisors LLC | SC 13D/A | 12,815,113 | 10.1% | Jun 20, 2025 | SEC filing |
| Mar 5, 2025 | Parag Mallick | SC 13D/A | 22,263,911 | 17.4% | Mar 3, 2025 | SEC filing |
| Mar 5, 2025 | Sujal Patel | SC 13D/A | 20,297,732 | 15.7% | Mar 3, 2025 | SEC filing |
One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.
Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).
Chart Signals
· Monthly Uptrend — Price above its 12-month moving average
Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.
| Filed | Items | Source |
|---|---|---|
| Oct 27, 2026 | 2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits | SEC filing |
| Sep 11, 2026 | 1.01 Entry into a Material Definitive Agreement · 1.02 Termination of a Material Definitive Agreement · 9.01 Financial Statements and Exhibits | SEC filing |
| Jul 28, 2026 | 2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits | SEC filing |
Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.
Stocks A–Z · Track Record: how the signals scored · Practice timing on NAUT
One email a week: the week’s new filings and research. Subscribe free
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.